Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 2,020 |
| Marketable Securities | 7,130 |
| Receivables | 3,390 |
| Other current assets | 80 |
| TOTAL | $12,620 |
| Non-Current Assets | |
| PPE Net | 9,380 |
| Other Non-Current Assets | 280 |
| TOTAL | $9,660 |
| Total Assets | $22,290 |
| Liabilities | |
| Current Liabilities | |
| Short Term Debt | 870 |
| Accounts payable and accrued liabilities | 1,190 |
| Other current liabilities | 8,210 |
| TOTAL | $10,600 |
| Non-Current Liabilities | |
| Long Term Debt | 3,570 |
| TOTAL | $3,576 |
| Total Liabilities | $14,180 |
| Shareholders' Equity | |
| Common Shares | 20 |
| Retained earnings | -28,900 |
| Other shareholders' equity | 29,130 |
| TOTAL | $8,110 |
| Total Liabilities And Equity | $22,290 |